The haemolytic effect of some phenothiazine derivatives.
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism; D002463:Cell Membrane Permeability; D002746:Chlorpromazine / Q000494:pharmacology*; D002951:Citrates; D003124:Colorimetry; D004492:Edetic Acid; D004912:Erythrocytes; D006461:Hemolysis; D007099:Imipramine / Q000494:pharmacology*; D066298:In Vitro Techniques; D010640:Phenothiazines / Q000494:pharmacology*; D011395:Promazine / Q000494:pharmacology*; D011398:Promethazine / Q000494:pharmacology*; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism; D012965:Sodium Chloride; D013501:Surface-Active Agents / Q000494:pharmacology; D013747:Tetrabenazine / Q000494:pharmacology*
D000925:Anticoagulants; D002951:Citrates; D010640:Phenothiazines; D013501:Surface-Active Agents; D012701:Serotonin; D012965:Sodium Chloride; D012110:Reserpine; D004492:Edetic Acid; D011398:Promethazine; D011395:Promazine; D007099:Imipramine; D002746:Chlorpromazine; D013747:Tetrabenazine